Intra-Cellular Therapies Inc header image

Intra-Cellular Therapies Inc

ITCI

Equity

ISIN US46116X1019 / Valor 23194616

NASDAQ (2024-09-18)

USD 74.70-0.55%

Intra-Cellular Therapies Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Intra-Cellular Therapies Inc is a biopharmaceutical company that focuses on developing therapies based on Dr. Paul Greengard's Nobel Prize-winning research on the inner workings of cells in the body. The company is led by experienced industry professionals and scientific advisors, aiming to bring innovative treatments to market for various medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

38.6%1Y

117%3Y

717%5Y

Performance

40.9%1Y

47.2%3Y

76.7%5Y

Volatility

7937 M

Market cap (USD)

127,857

Daily traded volume (Shares)

76.5 / 74.79

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc Valor: 123735674

Annual Return

-50%0%+50%

Risk level

110

2.00%USD 88.53

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc Valor: 1806798

Annual Return

-50%0%+50%

Risk level

110

-0.48%USD 273.15

Henry Schein Inc

Henry Schein Inc Valor: 83527

Annual Return

-50%0%+50%

Risk level

110

1.71%USD 72.46

BeiGene Ltd

BeiGene Ltd Valor: 30165310

Annual Return

-50%0%+50%

Risk level

110

-0.12%USD 197.28

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

-0.07%EUR 73.95

Almirall SA

Almirall SA Valor: 3180354

Annual Return

-50%0%+50%

Risk level

110

0.12%EUR 8.51

Pharma Mar SA

Pharma Mar SA Valor: 56130572

Annual Return

-50%0%+50%

Risk level

110

5.65%EUR 45.26

KK Kose

KK Kose Valor: 1017515

Annual Return

-50%0%+50%

Risk level

110

-0.88%JPY 7,930.00

Kobayashi Seiyaku KK

Kobayashi Seiyaku KK Valor: 511490

Annual Return

-50%0%+50%

Risk level

110

0.35%JPY 5,437.00

Hologic Inc

Hologic Inc Valor: 939263

Annual Return

-50%0%+50%

Risk level

110

-0.34%USD 81.72

SIX

FactSet

Clearbit

Logos provided by Clearbit